Search
for

    Sort by

    Research 91–120 of 1000+

    1. Recovery From Alopecia After COVID-19 Cureus · 2022 · 8 citations
    2. Symptom Trajectories and Long-Term Sequelae of COVID-19: A Matched Case–Control Study with Population-Based Controls Journal of Clinical Medicine · 2026
    3. Telogen effluvium and COVID-19: a cross-sectional study. PubMed · 2023
    4. CARACTERÍSTICAS CLÍNICAS DO EFLÚVIO TELÓGENO INDUZIDO PELA INFECÇÃO DE COVID-19: REVISÃO INTEGRATIVA Revista CPAQV - Centro de Pesquisas Avançadas em Qualidade de Vida · 2023
    5. Dermatological manifestations associated with COVID‐19 and COVID‐19 vaccination: results from the Lebanese COVID registry International Journal of Dermatology · 2023
    6. Cutaneous sarcoidosis post platelet‐rich plasma injections: A case report during the COVID pandemic Journal of cosmetic dermatology · 2023
    7. SARS-CoV-2 Infection—A Trigger Factor for Telogen Effluvium: Review of the Literature with a Case-Based Guidance for Clinical Evaluation Life · 2023 · 2 citations
    8. A poszt-COVID–19-szindróma (long-COVID) tünetei és a rehabilitáció lehetőségei Orvosi Hetilap · 2024
    9. Telogen Effluvium and COVID-19 DOAJ (DOAJ: Directory of Open Access Journals) · 2022
    10. The Need to Analyze Telogen Effluvium and Alopecia Areata Parallelly in Long COVID Studies Influenza and Other Respiratory Viruses · 2024
    11. Intermittent chronic telogen effluvium with an unusual dermoscopic finding Authorea (Authorea) · 2022
    12. Early-onset effluvium secondary to COVID-19: Clinical and histologic characterization Journal of The American Academy of Dermatology · 2021 · 7 citations
    13. The effect of COVID‐19 on development of hair and nail disorders: a Turkish multicenter, controlled study International Journal of Dermatology · 2022 · 3 citations
    14. Viruses, Variants, and Vaccines: How COVID-19 Has Changed the Way We Look at Skin Current Dermatology Reports · 2022 · 1 citations
    15. Telogen Effluvium Following Coronavirus Disease-2019 Infection: A Retrospective Study of 113 Cases International Journal of Trichology · 2025
    16. Telogen Effluvium and COVID-19: a case and a brief review of literature Medicina · 2022
    17. Reply to early onset effluvium secondary to COVID-19 and body-hair effluvium Journal of The American Academy of Dermatology · 2021
    18. COVID ‐19 induced telogen effluvium Dermatologic Therapy · 2021 · 22 citations
    19. INFLUÊNCIA DO VÍRUS DA COVID-19 NO AUMENTO DO NÚMERO DE CASOS DE EFLÚVIO TELÓGENO Zenodo (CERN European Organization for Nuclear Research) · 2023
    20. Dermatologic Changes in Experimental Model of Long COVID Microorganisms · 2024 · 1 citations
    21. Dermoscopy-assisted prevalence of hair loss after COVID-19 vaccination among an Egyptian population: a cross-sectional study Irish Journal of Medical Science (1971 -) · 2023 · 1 citations
    22. Peculiarities of long-COVID-19 and treatment strategy: a clinical case Zenodo (CERN European Organization for Nuclear Research) · 2021
    23. Prevalence of post–COVID syndrome in a cohort of faculty of a medical institute and their family members Anaesthesia Pain & Intensive Care · 2022 · 1 citations
    24. A hair loss pandemic: 19 cases of COVID-19 induced telogen effluvium Journal of clinical images and medical case reports · 2022
    25. Beau’s Lines and COVID-19; A Systematic Review on Their Association Pathogens · 2024 · 1 citations
    26. Long COVID and Post-Covid Conditions (PCC) in 2025 Digital Commons - East Tennessee State University (East Tennessee State University) · 2025
    27. Italian Survey for the Evaluation of the Effects of Coronavirus Disease 2019 (COVID-19) Pandemic on Alopecia Areata Recurrence Dermatology and Therapy · 2021 · 24 citations
    28. Characteristics of telogen effluvium in COVID-19 in western Iran (2020) Anais Brasileiros De Dermatologia · 2021 · 7 citations
    29. Increased risk of chronic fatigue and hair loss following COVID-19 in individuals with hypohidrotic ectodermal dysplasia Orphanet Journal of Rare Diseases · 2021 · 2 citations
    30. “Why we should treat COVID-19 Long Hauler Syndromes with Convalescent Plasma; Contained Suppressive Exosomes are likely COVID antigen-specific” 2021